// App-Quantinova.ai

: COMPARISON OF STANDARDIZED TREATMENT EFFECT SIZES FOR INVASIVE AND NON-INVASIVE ENDPOINTS IN PULMONARY ARTERIAL HYPERTENSION: INSIGHTS FROM THE REPAIR STUDY

Researchers

Presenter

  • David G. Kiely

Principal Investigators

  • Richard Channick

  • Dayana Flores

  • Nazzareno Galiè

  • J. Tim Marcus

  • Andrew Peacock

  • Stephan Rosenkranz

  • Ahmed Tawakol

  • Adam Torbicki

  • Anton Vonk Noordegraaf

  • Graham Wetherill

  • Andrew J. Swift

Medical Centers

  • Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom,

Locations

  • Switzerland

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

Disease

  • Pulmonary arterial hypertension

  • Stroke

Biomarkers

  • N-terminal pro b-type natriuretic peptide

Drug/Treatment

  • macitentan

Outcome

  • N/A

Study Design

  • Open Label

  • Single Arm

  • Multicenteric

Phase

  • IV

Study Id's

  • NCT02310672

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved